Vertex Pharmaceuticals Inc (VRTX) has a market cap of $112.77B and a current share price of $443.92, which is significantly below its 52-week high of $510.77, indicating potential upside. The company's revenue growth year-over-year stands at 8.90%, and it boasts a robust ROE of 22.70%, suggesting effective management and profitability. Despite a recent earnings miss in Q4 2025 with actual earnings of $5.03 compared to estimates of $5.17, the consensus remains strong with 13 Strong Buy and 20 Buy ratings.